Loading the section
The price of InMed Pharmaceuticals Inc. (INM) on October 9, 2026 is 1.38 USD, +3.76% on the day. Over 52 weeks the stock traded between 0.5750 USD and 2.50 USD; the price now sits 39% of the way up that range. Over the past year the price changed by -41.15%. Market capitalization is 1.30 million USD, rank 358 among 374 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
InMed Pharmaceuticals Inc. trades on Nasdaq under the ticker INM. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks INM has traded between 0.5750 $ and 2.44 $. As of 09 October 2026 the price stood 42.09 % of the way from the 52-week low to the high.
Over one year INM shares fell 44.72 %; over six months they rose 89.94 %. Volatility over 90 days is 52.78 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 0.3, below the sector median of 4.0. Price to book is 0.2, below the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 1.35 | 1.44 | 1.35 | 1.36 | 55,800 |
| 08 October 2026 | 1.32 | 1.36 | 1.32 | 1.33 | 26,800 |
| 07 October 2026 | 1.35 | 1.35 | 1.33 | 1.33 | 16,100 |
| 06 October 2026 | 1.38 | 1.38 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:1445-885 WEST GEORGIA ST., VANCOUVER, BC, V6C 3E8, CA
InMed Pharmaceuticals Inc. reported revenue of 5M $ and a net loss of 9M $ over the last four quarters. Revenue changed by −6.73 % year over year. Earnings per share are −2.12 $. Market capitalisation is 1M $.
INM has a return on equity of −123.48 %, below the sector median of −41.68 %. Return on assets is −93.17 %, below the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 1.32 |
| 1.33 |
| 17,700 |
| 05 October 2026 | 1.36 | 1.39 | 1.33 | 1.33 | 29,600 |
| 02 October 2026 | 1.37 | 1.39 | 1.33 | 1.33 | 28,300 |
| 01 October 2026 | 1.34 | 1.37 | 1.32 | 1.35 | 100,000 |
| 30 September 2026 | 1.35 | 1.41 | 1.34 | 1.36 | 60,700 |
| 29 September 2026 | 1.35 | 1.42 | 1.34 | 1.38 | 60,500 |
| 28 September 2026 | 1.36 | 1.37 | 1.36 | 1.36 | 17,400 |
| 25 September 2026 | 1.38 | 1.40 | 1.35 | 1.38 | 100,700 |
| 24 September 2026 | 1.39 | 1.42 | 1.37 | 1.40 | 39,000 |
| 23 September 2026 | 1.39 | 1.41 | 1.38 | 1.38 | 49,200 |
| 22 September 2026 | 1.39 | 1.44 | 1.37 | 1.39 | 38,300 |
| 21 September 2026 | 1.38 | 1.46 | 1.37 | 1.38 | 120,000 |
| 18 September 2026 | 1.39 | 1.40 | 1.36 | 1.36 | 10,400 |
| 17 September 2026 | 1.49 | 1.51 | 1.32 | 1.39 | 317,200 |
| 16 September 2026 | 1.26 | 1.31 | 1.26 | 1.28 | 54,900 |
| 15 September 2026 | 1.27 | 1.31 | 1.25 | 1.28 | 79,100 |
| 14 September 2026 | 1.29 | 1.32 | 1.27 | 1.30 | 58,500 |